Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients

被引:0
|
作者
Christine Robin
François Hémery
Christel Dindorf
Julien Thillard
Ludovic Cabanne
Rabah Redjoul
Florence Beckerich
Christophe Rodriguez
Cécile Pautas
Andrea Toma
Sébastien Maury
Isabelle Durand-Zaleski
Catherine Cordonnier
机构
[1] Assistance Publique-Hopitaux de Paris (APHP),Department of Hematology
[2] Henri Mondor Teaching Hospital,Department of Medical Information
[3] University Paris-Est Créteil (UPEC),Department of Virology, and INSERM U955 Team 18
[4] APHP,Department of Public Health
[5] Henri Mondor Teaching Hospital,undefined
[6] URC-Eco APHP ECEVE UMRS 1123,undefined
[7] APHP,undefined
[8] Henri Mondor Teaching Hospital,undefined
[9] APHP,undefined
[10] Henri Mondor Teaching Hospital,undefined
来源
关键词
Allogeneic stem cell transplantation; CMV infection; Antivirals; Costs;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Economic Burden of Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Spanish Multicenter, Retrospective Study
    Vazquez, Lourdes
    Sanz, Jaime
    Rovira, Montserrat
    Espigado, Ildefonso
    Rojas, Rafael
    Lopez, Javier
    Esquirol, Albert
    Bermudez, Maria Aranzazu
    De la Camara, Rafael
    Saldana, Raquel
    Inmaculada Heras, Maria
    Julia Gonzalez, Ana
    Batlle, Montserrat
    Torrado, Tamara
    Vallejo, Carlos
    Angeles Cuesta, Maria
    Barba, Pere
    Jimenez, Santiago
    Francisco Duarte, Rafael
    Tang, Yuexin
    Lozano, Virginia
    Maratia, Stefano
    Munoz, Alvaro
    Solano, Carlos
    [J]. BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 399 - 400
  • [22] CMV infection and disease after allogeneic stem cell transplantation with reduced-intensity conditioning
    Avetisyan, G.
    Hagglund, H.
    Hassan, Z.
    LeBlanc, K.
    Mattsson, J.
    Ringden, O.
    Winiarski, J.
    Ljungman, P.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S241 - S242
  • [23] PROPHYLAXIS OF CMV INFECTION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION WITH NILOTINIB : A PHASE II TRIAL
    Lin, C. T.
    Wu, S. J.
    Li, C. C.
    Ko, B. S.
    Yao, M.
    Lin, W. P.
    Tang, J. L.
    Tien, H. F.
    [J]. HAEMATOLOGICA, 2014, 99 : 423 - 423
  • [24] Valganciclovir for the early prophylaxis of cytomegalovirus (CMV) infection after allogeneic stem cell transplantation.
    Bachier, C
    Shaughnessy, P
    Wall, D
    Grimley, M
    Carrum, G
    Freytes, C
    Callander, N
    Walsh, T
    LeMaistre, CF
    [J]. BLOOD, 2004, 104 (11) : 352B - 352B
  • [25] CMV infection plays a crucial role in the immune reconstitution after allogeneic stem cell transplantation
    Hartjen, A. S.
    Krumbholz, A.
    Thieme, F.
    Bulduk, M.
    Humpe, A.
    Gramatzki, M.
    Guenther, A.
    [J]. Oncology Research and Treatment, 2015, 38 : 45 - 45
  • [26] IMMUNE RECONSTITUTION AND RISK OF CYTOMEGALOVIRUS INFECTION IN PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: IMPLICATIONS FOR PREEMPTIVE AND PROPHYLACTIC STRATEGIES
    Schmidt-Hieber, M.
    Schwarck, S.
    Stroux, A.
    Thiel, E.
    Tillmann, H.
    Reinke, P.
    Ganepola, S.
    Uharek, L.
    Blau, I.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 53 - 53
  • [27] Incidence of CMV infection and CMV disease in allogeneic transplanted patients: From no prophylaxis to preemptive treatment.
    Meuleman, N
    Debruyne, JM
    Jacquy, C
    Bron, D
    [J]. BLOOD, 2000, 96 (11) : 341B - 341B
  • [28] Major central nervous system complications after allogeneic stem cell transplantation: A large retrospective study on 888 consecutive adult patients
    Mannina, Daniele
    Berneking, Laura
    Both, Anna
    Timm, Wiebke
    Urbanowicz, Tatiana
    Wolschke, Christine
    Ayuketang Ayuk, Francis
    Fischer, Nicole
    Fiehler, Jens
    Grzyska, Ulrich
    Roesner, Sabine
    Choe, Chi-Un
    Kroeger, Nicolaus
    Christopeit, Maximilian
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (06) : 722 - 730
  • [29] CMV infection and disease in 100 allogeneic BMT patients: From no prophylaxis to preemptive treatment
    Bron, D
    Meuleman, N
    Debruyne, JM
    Maerevoet, M
    Rizopoulo, H
    Stryckmans, P
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 208 - 209
  • [30] The clinical and economic burden of cytomegalovirus management post allogeneic hematopoietic stem cell transplantation in Japan - a retrospective database study
    Ueno, Rie
    Nishimura, Shinichi
    Fujimoto, Go
    Piao, Yi
    Takenaka, Katsuto
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (12) : 2089 - 2096